Articles from BIOTECH Patent News (August 1, 2000)

1-55 out of 55 article(s)

Title	Type	Words
Abbott obtains United States patent.	Brief Article	68
Amgen obtains United States patent.	Brief Article	43
Biogen and Elan to collaborate on multiple sclerosis monoclonal antibody.	Brief Article	569
Biogen praises Court ruling that Avonex does not infringe Berlex 'McCormick' patents.	Brief Article	346
Biosytes awarded patent for Bio-Solv process for Q-Gel (Coenzyme Q10) Softsules.	Brief Article	246
Biotransport carriers could assist in discovery of new therapies from the human genome.	Brief Article	358
Boehringer Ingelheim obtains United States patent.	Brief Article	51
Cell Genesys applies for patent.	Brief Article	45
Cell Genesys exclusively licenses technology for liver-directed Aav gene therapy from University of Washington.	Brief Article	744
Collateral announces expanded angiogenic gene research collaboration with New York University.	Brief Article	437
Collateral announces issuance of United States patent for angiogenic gene therapy for the treatment of heart disease.	Brief Article	559
Dana Farber applies for patent.	Brief Article	38
Erasums University Rotterdam obtains United States patent.	Brief Article	57
Eurogene and Valentis announce collaboration to develop gene medicine to inhibit restenosis.	Brief Article	489
Genentech obtains United States patent.	Brief Article	52
Genentech obtains United States patent.	Brief Article	38
Genset applies for patent.	Brief Article	44
Genta announces licensing deal for antisense technology to Sequitur.	Brief Article	307
Genvec announces broad gene therapy patent.	Brief Article	196
Genzyme Molecular Oncology licenses cancer diagnostic patent rights to three diagnostic laboratories.	Brief Article	648
Genzyme obtains Unite d States patent.	Brief Article	59
Hoechst obtains United States patent.	Brief Article	56
Huels obtains United States patent.	Brief Article	39
Idexx obtains United States patent.	Brief Article	57
Incyte applies for patent.	Brief Article	38
Incyte obtains United States patent.	Brief Article	24
Isis Pharmaceuticals' Genetrove division and the R.W. Johnson Pharmaceutical Research Institute initiate antisense target validation program.	Brief Article	432
Johns Hopkins obtains United States patent.	Brief Article	37
McGill University grants exclusive license to Mycota Biosciences for novel fungal genomics technology.	Brief Article	411
Medarex and Athersys announce collaboration to develop human antibody therapeutics.	Brief Article	481
Mercator Genetics obtains United States patent.	Brief Article	56
Michigan State University obtains United States patent.	Brief Article	37
Millennium applies for patent.	Brief Article	46
Northwestern applies for patent.	Brief Article	41
Nova Molecular obtains United States patent.	Brief Article	37
Novo Nordisk obtains United States patent.	Brief Article	158
Novo Nordisk obtains United States patent.	Brief Article	48
Pennsylvania State University applies for patent.	Brief Article	35
PerSeptive Biosystems obtains United States patent.	Brief Article	33
Regeneron obtains United States patent.	Brief Article	48
Select Therapeutics announces research agreement with University of Arizona Cancer Center.	Brief Article	283
Sequenom and University of Texas Southwestern commence record Snp and disease association oroject.	Brief Article	843
SIBIA obtains United States patent.	Brief Article	54
SmithKline Beecham applies for patent.		32
Taisho applies for patent.	Brief Article	39
The Wistar Institute obtains United States patent.	Brief Article	55
Thomas Jefferson University applies for patent.	Brief Article	40
University of Alabama-Birmingham applies for patent.	Brief Article	34
University of Glasgow obtains United States patent.	Brief Article	60
University of Iowa applies for patent.		38
University of Miami applies for patent.	Brief Article	32
University of Tulsa obtains United States patent.	Brief Article	68
University of Washington obtains United States patent.	Brief Article	34
Washington Research Foundation obtains United States patent.	Brief Article	34
Zymogenetics applies for patent.		36